Previous 10 | Next 10 |
Last week, the top-performing biotech stocks had something in common and by now you can probably guess exactly what that was. You got it. They both delivered positive press releases regarding their respective coronavirus vaccine candidates. Data source: Yahoo! Finance. Continue reading
BioHiTech Global (NASDAQ: BHTG ) +89% on potential demand for Altapure disinfectant in COVID-19. More news on: BioHiTech Global, Inc., Kiniksa Pharmaceuticals, Ltd., CleanSpark, Inc., Stocks on the move, , Read more ...
Vaxart (NASDAQ: VXRT) and VBI Vaccines (NASDAQ: VBIV) are both young vaccine companies seeking to develop a vaccine for COVID-19. Neither company is profitable, but both stocks have experienced triple-digit growth in the last three months. Future stock growth stemming from advances in v...
Vaccine startup Vaxart (NASDAQ: VXRT) announced Thursday morning that it was initiating a memorandum of understanding with Attwill Medical Solutions Sterilflow. The latter company will produce components for Vaxart's COVID-19 vaccine candidate currently in preclinical development, and Vaxart...
Shares of Vaxart (NASDAQ: VXRT) soared on Friday after the biotech company said that its oral COVID-19 vaccine had been selected to receive funding from a federal government program aiming to deliver hundreds of millions of safe and effective coronavirus vaccine doses to Americans by Janua...
Gainers: MDC Partners (NASDAQ: MDCA ) +95% . More news on: MDC Partners Inc., Vaxart, Inc., iBio, Inc., Stocks on the move, , Read more ...
Vaxart (NASDAQ: VXRT ) is surging for the second day in a row, up 70% pre-market, after the U.S. Government selected their oral vaccine as eligible to participate in a non-human study organized and funded as part of Operation "Warp Speed." More news on: Vaxart, Inc., AstraZeneca PLC, Jo...
MDC Partners (NASDAQ: MDCA ) +169% on potential business combination with Stagwell. More news on: MDC Partners Inc., Vaxart, Inc., iBio, Inc., Stocks on the move, , Read more ...
SOUTH SAN FRANCISCO, Calif., June 26, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that its oral COVID-19 vaccine has been selected to participate in a non-hum...
Vaxart (NASDAQ: VXRT ) +25% after-hours after touching a new all-time high $6.48 during today's trade before closing up 96%, after saying it signed an MoU with Attwill Medical Solutions Sterilflow to use AMS' resources for lyophilization development and large scale manufacturing includin...
News, Short Squeeze, Breakout and More Instantly...
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the second quarter ended June 30, 2024 after the market close on Thursd...
— Cash runway extended into 2026 — — Received one of the largest BARDA-funded Project NextGen Awards to date, up to $453 million — — Company well-capitalized to execute on multiple key clinical and regulatory milestones in COVID-19 and noroviru...
A look at the top 10 most actives in the United States SRIVARU Holding Limited (SVMH) rose 94.8% to $0.2971 on volume of 77,516,058 shares NVIDIA Corporation (NVDA) fell 0.3% to $129.16 on volume of 39,120,242 shares Longeveron Inc. (LGVN) rose 27.0% to $3.415 on volume of 36,214,736 shar...